Skip to main content


Figure 4 | BMC Complementary and Alternative Medicine

Figure 4

From: Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine

Figure 4

The iluem immunohistochemistry for GLP1R and MAPK10 expression (original magnification ×  200) and semiquantitative assessments. A-B Immunostaining for GLP1R. C-D immunostaining for MAPK10. Iluem were harvested form DM (A, C) and berH group (B, D). (E) Semiquatitatve scores of GLP1R and MAPK10. Data represent mean ± SD (n = 6). #P < 0.05 versus DM group.

Back to article page